281 related articles for article (PubMed ID: 33488527)
1. Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis.
Wu Z; Zhu Y; Zhang M; Wang C; Zhou L; Liu W; Yang W; Li M; Zhang S; Ren Q; Han X; Ji L
Front Endocrinol (Lausanne); 2020; 11():620407. PubMed ID: 33488527
[TBL] [Abstract][Full Text] [Related]
2. [Application of the superior thyroid artery peak systolic velocity in differentiating Graves' disease from autoimmune thyroiditis].
Wang C; Zhu Y; Zhou LL; Zhao YY; Han XY; Ji LN
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):207-212. PubMed ID: 32146747
[No Abstract] [Full Text] [Related]
3. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil/Monocyte Ratio Combined With Serum Thyroid Hormone for Distinguishing Graves' Disease and Subacute Thyroiditis.
Hu Y; Zhou D; Chen J; Shan P
Front Endocrinol (Lausanne); 2020; 11():264. PubMed ID: 32457697
[No Abstract] [Full Text] [Related]
6. The value of FT4/TSH ratio in the differential diagnosis of Graves' disease and subacute thyroiditis.
Zhang Y; Wang Y; Liu M; Wei L; Huang J; Dong Z; Guan M; Wu W; Gao J; Huang X; Guo X; Xie P
Front Endocrinol (Lausanne); 2023; 14():1148174. PubMed ID: 37396175
[TBL] [Abstract][Full Text] [Related]
7. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study.
Tura Bahadır Ç; Yılmaz M; Kılıçkan E
Int J Clin Pract; 2021 May; 75(5):e14003. PubMed ID: 33403716
[TBL] [Abstract][Full Text] [Related]
8. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the diagnostic performance of thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease.
Xu S; Shao W; Wu Q; Zhu J; Pan B; Wang B; Guo W
J Clin Lab Anal; 2023 Apr; 37(8):e24890. PubMed ID: 37161617
[TBL] [Abstract][Full Text] [Related]
10. Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.
Sriphrapradang C; Bhasipol A
Ann Med Surg (Lond); 2016 Sep; 10():69-72. PubMed ID: 27570620
[TBL] [Abstract][Full Text] [Related]
11. Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests.
Cappellani D; De Marco G; Ferrarini E; Torregrossa L; Di Certo AM; Cosentino G; Urbani C; Marconcini G; Mattiello A; Manetti L; Agretti P; Basolo F; Tonacchera M; Bartalena L; Bogazzi F
Thyroid; 2021 Oct; 31(10):1463-1471. PubMed ID: 34271828
[No Abstract] [Full Text] [Related]
12. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
Stan MN; Algeciras-Schimnich A; Murthy V; Thapa P; Araki N
Thyroid; 2022 Feb; 32(2):170-176. PubMed ID: 34714163
[No Abstract] [Full Text] [Related]
13. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
14. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
16. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Yoshihara A; Noh JY; Mukasa K; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Watanabe N; Suzuki N; Kameda T; Sugino K; Ito K
Endocr J; 2015; 62(6):557-60. PubMed ID: 25819223
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.
Wang F; Zhang SJ; Yao X; Tian DM; Zhang KQ; She DM; Guo FF; Zhai QW; Ying H; Xue Y
Endocrine; 2017 Jul; 57(1):125-137. PubMed ID: 28547036
[TBL] [Abstract][Full Text] [Related]
18. Quantitative thyroid scintigraphy for the differentiation of Graves' disease and hyperthyroid autoimmune thyroiditis.
Sahlmann CO; Siefker U; Lehmann K; Harms E; Conrad M; Meller J
Nuklearmedizin; 2004 Aug; 43(4):124-8. PubMed ID: 15316579
[TBL] [Abstract][Full Text] [Related]
19. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
Izumi Y; Takeoka K; Amino N
Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
